Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice
Eleni Bazigou, … , Nigel A. Brown, Taija Makinen
Eleni Bazigou, … , Nigel A. Brown, Taija Makinen
Published July 18, 2011
Citation Information: J Clin Invest. 2011;121(8):2984-2992. https://doi.org/10.1172/JCI58050.
View: Text | PDF
Research Article Vascular biology

Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice

  • Text
  • PDF
Abstract

Chronic venous disease and venous hypertension are common consequences of valve insufficiency, yet the molecular mechanisms regulating the formation and maintenance of venous valves have not been studied. Here, we provide what we believe to be the first description of venous valve morphogenesis and identify signaling pathways required for the process. The initial stages of valve development were found to involve induction of ephrin-B2, a key marker of arterial identity, by venous endothelial cells. Intriguingly, developing and mature venous valves also expressed a repertoire of proteins, including prospero-related homeobox 1 (Prox1), Vegfr3, and integrin-α9, previously characterized as specific and critical regulators of lymphangiogenesis. Using global and venous valve–selective knockout mice, we further demonstrate the requirement of ephrin-B2 and integrin-α9 signaling for the development and maintenance of venous valves. Our findings therefore identified molecular regulators of venous valve development and maintenance and highlighted the involvement of common morphogenetic processes and signaling pathways in controlling valve formation in veins and lymphatic vessels. Unexpectedly, we found that venous valve endothelial cells closely resemble lymphatic (valve) endothelia at the molecular level, suggesting plasticity in the ability of a terminally differentiated endothelial cell to take on a different phenotypic identity.

Authors

Eleni Bazigou, Oliver T.A. Lyons, Alberto Smith, Graham E. Venn, Celia Cope, Nigel A. Brown, Taija Makinen

×

Figure 5

Integrin-α9 and ephrin-B2 are required for the development of venous valves.

Options: View larger image (or click on image) Download as PowerPoint
Integrin-α9 and ephrin-B2 are required for the development of venous val...
(A and B) SEM images of venous valves (arrows) in P6 WT (A) and Itga9–/– (B; 5 valves) mice. (C–F) SEM images of venous valves in control (C; 10 valves), Itga9lx/lx;Prox1-CreERT2 (D; 7 valves), Fn-EIIIA–/– (E; 8 valves), and Efnb2lx/lx;Prox1-CreERT2 (F; 10 valves) mice at P11. Arrows, valves in external iliac veins; arrowheads, valves in internal iliac veins. Note the rudimentary valves in the external iliac vein and absent valves (asterisks) in the internal iliac vein in the mutant mice. (G–L) Immunofluorescence staining of iliac veins of R26-mTmG;Prox1-CreERT2 (G and H), Itga9lx/lx;Prox1-CreERT2 (I and J; n = 2), and Efnb2lx/lx;R26-mTmG;Prox1-CreERT2 (K and L; n = 3) mice at P7, after administration of 4-OHT at P2, using an antibody against Prox1 (red). PECAM-1 antibodies were used to visualize endothelial cells in I. Note the endothelial cells on the free ends of the valve leaflets (arrows) showed colocalization of GFP and strong Prox1 immunolabeling (G and H), reduced number of Prox1-positive cells in Itga9 mutants (I and J), and loss of Prox1-positive cells in Efnb2 mutants (K and L). Asterisks in K and L denote a lymphatic vessel. Scale bars: 100 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts